| Literature DB >> 34790620 |
Jan Adamski1, Björn Jäschke2, Tuomas Nieminen3, Wojciech Weigl4.
Abstract
We report the use of anakinra to treat a case of a 64-year-old man diagnosed with haemophagocytic lymphohistiocytosis (HLH) with neurological involvement. After the administration of intravenous pulse corticosteroid therapy, immunoglobulin and anakinra the patient showed neurological recovery. However, the recovery was complicated by the perforation of a pre-existing bowel diverticulum. The effect of anakinra on bowel inflammation has not yet been clearly established. It can potentially augment bowel inflammation and contribute to the risk of bowel perforation associated with the concomitant use of corticosteroids. LEARNING POINTS: Anakinra can potentially augment bowel inflammation.The concomitant use of anakinra and corticosteroids may increase the risk of bowel perforation.Use of anakinra and corticosteroids in patients with pre-existing gastrointestinal diseases requires vigilant observation for abdominal symptoms. © EFIM 2021.Entities:
Keywords: Diverticulitis; gastrointestinal diseases; gut; haemophagocytic lymphohistiocytosis (HLH); interkeukin-1 (IL-1) receptor antagonist
Year: 2021 PMID: 34790620 PMCID: PMC8592665 DOI: 10.12890/2021_002842
Source DB: PubMed Journal: Eur J Case Rep Intern Med ISSN: 2284-2594